期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Analysis on Reverse of Atypical Endometrial Hyperplasia by Drugs in Patients with Polycystic Ovary Syndrome 被引量:1
1
作者 xiao-fang lou Jin-fang LIN +1 位作者 Su-ping FANG Feng-ling WANG 《Journal of Reproduction and Contraception》 CAS 2013年第4期205-214,共10页
Objective To analyze the efficacy and safety of drugs on reverse of atypical endometrial hyperplasia in patients with polycystic ovary syndrome (PCOS). Methods Seventeen patients with PCOS complicated by atypical en... Objective To analyze the efficacy and safety of drugs on reverse of atypical endometrial hyperplasia in patients with polycystic ovary syndrome (PCOS). Methods Seventeen patients with PCOS complicated by atypical endometrial hyperplasia (9 patients who were treated with progestin but not reversed were considered as group A; 8 patients who were untreated were considered as group B) were retrospectively analyzed Both groups received oral glucose tolerance test (OGTT) and insulin release test, to check whether the patients had insulin resistance (IR) or hyperinsulinemia. The 17 patients were treated with oral contraceptives combined with metformin. Results After the 17 patients with PCOS complicated by IR and hyperinsulinemia received drug treatment for 3 -6 cycles, atypical endometrial hyperplasia was success- fully reversed Conclusion Oral contraceptives combined with metformin is a clinically practical and effective method for treatment of PCOS complicated by atypical insulin-resistant endometrial hyperplasia. 展开更多
关键词 polycystic ovary syndrome (PCOS) atypical endometrial hyperplasia insulinresistance (IR) oral contraceptives METFORMIN
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部